No abstract available
Keywords:
assembloid learning; brain organoids (BOs); machine learning (ML); neurodegenerative diseases; organoid intelligence; personalized medicine.
Grants and funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. FG's contribution was partially funded by the Italian Ministry of Health (Ricerca Corrente # 10/1701).